Combination Therapy of Montelukast and Desloratadine in Pediatric Allergic Rhinitis: Effects on Symptoms and Inflammatory Markers
Journal of Visualized Experiments · 2026-10-30 · (236)
DOI: 10.3791/73250 ↗At a glance
Video/Audio in Journal of Visualized Experiments, published online on 2026-10-30. Written by Jingfeng Wang and 3 co-authors. Institution: Department of Otolaryngology-Head & Neck Surgery, The First Hospital of Putian. Major MEDLINE topics: Loratadine, Acetates, Quinolines, Rhinitis, Allergic.
Abstract (original language)
This retrospective, controlled study evaluated the clinical outcomes of montelukast sodium combined with desloratadine syrup in pediatric patients with allergic rhinitis. Medical records from 360 children aged 6-12 years treated between October 2021 and November 2024 were reviewed. Patients were classified according to documented treatment as desloratadine monotherapy (Group A, n = 180) or desloratadine plus montelukast (Group B, n = 180). During the 4-week treatment period, Total Nasal Symptom Score (TNSS), Total Non-Nasal Symptom Score (TNNSS), time to symptom improvement, serum immunoglobulin E (IgE), interleukin-13 (IL-13), eosinophil counts, and adverse events were assessed. Group B had lower post-treatment TNSS (4.65 ± 2.12 vs 5.32 ± 2.09, p = 0.003) and TNNSS (1.96 ± 1.43 vs 2.48 ± 1.01, p < 0.001), and rhinorrhea improved sooner (10.38 ± 1.87 vs 13.48 ± 1.20 days, p < 0.001). Greater reductions were also observed in inflammatory markers, including IgE and IL-13 (90.36 ± 22.58 vs 102.78 ± 19.25 ng/L, p < 0.001). Adverse-event rates did not differ significantly (0.56% vs 1.67%; Fisher's exact test, p = 0.623), although only four events were recorded. These findings indicate that combination therapy was associated with greater improvements in clinical symptoms and inflammatory markers than desloratadine monotherapy; however, the retrospective, nonrandomized design and limited safety events require cautious interpretation.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Otolaryngology-Head & Neck Surgery, The First Hospital of Putian.
- The School of Clinical Medicine, Fujian Medical University.
- The School of Clinical Medicine, Fujian Medical University; mytw565788234@163.com.
Cite
APA
Wang, J., Huang, D., Cai, Z., & Lin, Q. (2026). Combination Therapy of Montelukast and Desloratadine in Pediatric Allergic Rhinitis: Effects on Symptoms and Inflammatory Markers. Journal of Visualized Experiments. https://doi.org/10.3791/73250
Vancouver
Wang J, Huang D, Cai Z, Lin Q. Combination Therapy of Montelukast and Desloratadine in Pediatric Allergic Rhinitis: Effects on Symptoms and Inflammatory Markers. Journal of Visualized Experiments. 2026. doi:10.3791/73250
BibTeX
@article{Wang2026,
author = {Wang, Jingfeng and Huang, Dongdong and Cai, Zhang and Lin, Qiming},
title = {Combination Therapy of Montelukast and Desloratadine in Pediatric Allergic Rhinitis: Effects on Symptoms and Inflammatory Markers},
journal = {Journal of Visualized Experiments},
year = {2026},
number = {236},
doi = {10.3791/73250}
}
EUVIMED